Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

ASK NEWS:
  • Type 2 Diabetes Global Clinical Trials Review, H1, 2014 - Sacramento Bee
    Autism advocates plea: don’t go home without passing treatment ... - Raleigh News & Observer
    07/15/2014 - 4:12 am | View Link
  • More
BING NEWS:
  • AstraZeneca to buy out Bristol stake in diabetes JV for up to $4.1 bn
    Speculation that AstraZeneca might look to buy out Bristol was fuelled last month ... received a boost when an advisory panel to the US Food and Drug Administration endorsed its new diabetes pill dapagliflozin. Reuters
    12/19/2013 - 5:12 pm | View Link
  • Astra to Buy Stake in Diabetes Venture From Bristol for Up to $4.1 Billion
    Earlier this year, Bristol and AstraZeneca deepened their partnership by merging their diabetes-drug marketing teams. But sales at the diabetes venture, which was established in 2007 to develop the therapy Onglyza, have disappointed analysts. AstraZeneca ...
    12/18/2013 - 11:31 pm | View Link
  • AstraZeneca to buy Bristol stake in diabetes venture for up to $4.1 bln
    Speculation that such a deal might be on the cards was fuelled last month after Bristol decided to exit diabetes drug research. The Bristol-AstraZeneca diabetes joint venture includes the oral medicines Onglyza, Kombiglyze and Forxiga, as well as the ...
    12/18/2013 - 6:58 pm | View Link
  • EU OKs Bristol-Myers, AstraZeneca diabetes drug
    (AP) -- Drugmaker Bristol-Myers Squibb Co. said Monday that its new diabetes drug, Onglyza, has been approved for sale in the European Union's 27 countries. (AP) — Drug maker Bristol-Myers Squibb Co. says it agreed to buy diabetes drug maker Amylin ...
    11/14/2012 - 6:58 am | View Link
  • Bristol-Myers to buy diabetes drug maker for $5 billion
    Bristol-Myers Squibb Co. said it plans to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash. Bristol-Myers will enter an agreement with British drug maker AstraZeneca to develop and commercialize Amylin's diabetes drugs, the ...
    07/2/2012 - 12:04 am | View Link
  • More
BING SEARCH:
  • BMY Stock Quote
    Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis ...
    08/1/2014 - 3:19 am | View Website
  • Where Can I Get Help Paying for Diabetic Medications? | eHow
    Where Can I Get Help Paying for Diabetic Medications?. Drug companies have recognized that some of their medications are cost prohibitive for many people. In an ...
    07/31/2014 - 7:41 pm | View Website
  • Diabetic retinopathy
    Diabetic retinopathy, is retinopathy (damage to the retina) caused by complications of diabetes, which can eventually lead to blindness. It is an ocular manifestation ...
    07/31/2014 - 9:11 am | View Website
  • Diabetes | News
    Get the latest Diabetes news headlines from Yahoo News. Find breaking Diabetes news with in-depth coverage including analysis and opinions.
    07/31/2014 - 3:28 am | View Website
  • Generic Drugs (Show All) :: Diabetes Self-Management
    People with diabetes often take multiple drugs, including blood-glucose-lowering pills or insulin, blood-pressure-lowering pills, and cholesterol-lowering ...
    07/30/2014 - 9:44 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News